UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000038970
Receipt No. R000044316
Scientific Title Investigation of methods for collecting substances causing odor from axillae for patients with osmidrosis axillae and volunteers
Date of disclosure of the study information 2019/12/24
Last modified on 2020/03/26 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Investigation of methods for collecting substances causing odor from axillae for patients with osmidrosis axillae and volunteers
Acronym Investigation of methods for collecting substances causing odor from axillae
Scientific Title Investigation of methods for collecting substances causing odor from axillae for patients with osmidrosis axillae and volunteers
Scientific Title:Acronym Investigation of methods for collecting substances causing odor from axillae
Region
Japan

Condition
Condition osmidrosis axillae
Classification by specialty
Dermatology Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate sampling methods of substances causing axillary odor by comparing following sampling methods, wiping axillae with alcohol cotton and
collecting skin gas from axillae with Mono Trap.
Basic objectives2 Others
Basic objectives -Others To investigate the relationship between amount of substances causing odor from axillae and axillary odor score exploratory.
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes Each collected amount of three substances causing odor from axillae by both methods.3-Hydroxy-3-methylhexanoic acid(HMHA)
3-Methyl-2-hexenoic acid (3M2H)
3-Methyl-3-sulfanylhexan-1-ol(3M3SH)
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
65 years-old >
Gender Male and Female
Key inclusion criteria 1)
Subject who has Japanese nationality and is from 20 to less than 65 years old at the time of informed consent
2)
For patients, subjects who has axillary odor score 1 or more
For volunteers, subjects who has axillary odor score 0
Key exclusion criteria 1)Subjects who has complications in axilla
2)Subjects who has any severe disease or medical history determined by investigator to be unsuitable for the study, e.g. liver, kidney, cardiac, digestive organ, circulatory organ, blood, et cetera.
3)For volunteers, subjects who has complications or medical history of osmidrosis axillae and who has been told that axillary odor by somebody
4)Subjects who has sensitivities for alcohol or has allergic reaction for medical tape
5)Subjects who are judged as ineligible for this study by the investigator
Target sample size 12

Research contact person
Name of lead principal investigator
1st name Takeshi
Middle name
Last name Ouchi
Organization Samoncho Clinic
Division name Medical office
Zip code 160-0017
Address Yotsuya Medical Bidg.20,Samoncho,Shinjuku-ku,Tokyo
TEL 03-5366-3641
Email takeshi-ouchi.z5@keio.jp

Public contact
Name of contact person
1st name Satoko
Middle name
Last name Shimizu
Organization Tokyo Research Center of Clinical Pharmacology
Division name Clinical Research Promotion
Zip code 160-0017
Address Yotsuya Medical Bidg.20,Samoncho,Shinjuku-ku,Tokyo
TEL 03-5366-3439
Homepage URL
Email s-shimizu@trcp.co.jp

Sponsor
Institute Samoncho Clinic
Institute
Department

Funding Source
Organization Maruho co.,ltd
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Shinanozaka Clinic
Address Yotsuya Medical Bidg.20,Samoncho,Shinjuku-ku,Tokyo
Tel 03-5366-3006
Email at-kubota@shinanokai.com

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 医療法人社団信濃会左門町クリニック(東京都)

Other administrative information
Date of disclosure of the study information
2019 Year 12 Month 24 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 12
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
none
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 10 Month 31 Day
Date of IRB
2019 Year 11 Month 12 Day
Anticipated trial start date
2019 Year 12 Month 22 Day
Last follow-up date
2020 Year 01 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information -

Management information
Registered date
2019 Year 12 Month 24 Day
Last modified on
2020 Year 03 Month 26 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044316